Whilst Northwest Biotherapeutics is working hard to achieve market access in as short a time as possible we do need to be realistic about what is achievable. We are privileged to be in dialogue with Northwest Biotherapeutics and we will of course keep you updated with any developments.
New #DCVax clinical trial results offer some much needed hope for the #glioblastoma community. Whilst this is positive news, we must be mindful of the challenges around parity of access. Read more on our website 👉 https://t.co/AHlTMB3XaU